A novel biodegradable stent applicable for use in congenital heart disease: Bench testing and feasibility results in a rabbit model

Catheterization and Cardiovascular Interventions

Volumn 83, Issue 3, 2014, Pages 448-456

  Veeram Reddy, Surendranath R ^a   Welch, Tre R ^a   Wang, Jian ^a   Bernstein, Frederic ^b,c   Richardson, James A ^a   Forbess, Joseph M ^a   Nugent, Alan W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Division of Pediatric Infectious Diseases   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

biodegradable stents; congenital heart disease; poly l lactic acid (PLLA)

Indexed keywords

BIODEGRADABLE STENTS; CONGENITAL HEART DISEASE; POLY-L-LACTIC ACID (PLLA);

ABSORBABLE IMPLANTS; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERITIS; CARDIAC CATHETERIZATION; CATHETERIZATION, PERIPHERAL; ELASTIC MODULUS; FEASIBILITY STUDIES; HEART DEFECTS, CONGENITAL; ILIAC ARTERY; LACTIC ACID; MALE; MATERIALS TESTING; MODELS, ANIMAL; NEOINTIMA; PILOT PROJECTS; POLYMERS; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RABBITS; STENTS; STRESS, MECHANICAL; TENSILE STRENGTH; THROMBOSIS; TIME FACTORS; ULTRASONOGRAPHY, INTERVENTIONAL; VASCULAR PATENCY;

EID: 84893780863     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24936     Document Type: Article

References (26)

1. Fischman D, Leon M, Baim D, Schatz RA, Savage MP, Penn I, Detre K, Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirstein PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Rake R, Goldberg S for the Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994; 331: 496-501.
2. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, van den, Heuvel P, Delcan J, Morel MA for the Benestent Study Group. A comparison of balloon expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-495.
3. Savage PM, Fischman DL, Schatz RA, Teirstein PS, Leon MB, Baim D, Ellis SG, Topol EJ, Hirshfeld JW, Cleman MW, Buchbinder M, Bailey S, Heuser R, Walker CM, Curry C, Gebhardt S, Rake R, Goldberg S,. Long-term angiographic and clinical outcome after implantation of a balloon-expandable stent in the native coronary circulation. J Am Coll Cardiol 1994; 24: 1207-1212.
4. Virmani R, Farb A, Guagliumi G, Kolodgie FD,. Drug-eluting stents: Caution and concerns for long-term outcome. Coron Artery Dis 2004; 15: 313-318.
5. Walksman R,. Promise and challenges of bioabsorbable stents. Catheter Cardiovasc Interv 2007; 70: 407-414.
6. Pederson WC, Singer DI, Angel MF, Mahoney JE, Mitchell GM, Morrison WA, O'Brien BM,. Hydrostatic distension and pharmacological treatment of epinephrine-induced microarterial spasm. Ann Plast Surg 1989; 23: 17-26.
7. LeVeen RF, Wolf GL, Biery D,. Angioplasty-induced vasospasm in rabbit model: Mechanisms and treatment. Invest Radiol 1985; 20: 938-944.
8. Welch T, Eberhart RC, Veeram Reddy S, Wang J, Nugent A, Forbess J,. Novel bioresorbable stent design and fabrication: Congenital heart disease applications. Cardiovasc Eng Tech 2013; 4: 171-182.
9. Zidar J, Lincoff AM, Stack R,. Biodegradable stents. In:, Topol EJ, editor. Textbook of Interventional Cardiology, 2nd ed. Philadelphia: WB Saunders; 1994. pp 787-802.
10. Tamai H, Igaki K, Tsuji T, Kosuga K, Kawashima A, Matsui S, Komori H, Motohara S, Uehata H, Takeuchi E,. A biodegradable poly- l -lactic acid coronary stent in the porcine coronary artery. J Interven Cardiol 1999; 12: 443-450.
11. Tamai H, Igaki K, Kyo E, Kosuga K, Kawashima A, Matsui S, Komori H, Tsuji T, Motohara S, Uehata H,. Initial and 6-month results of biodegradable poly- l -lactic acid coronary stents in humans. Circulation 2000; 102: 399-404.
12. Nishio S, Kosuga K, Igaki K, Okada M, Kyo E, Tsuji T, Takeuchi E, Inuzuka Y, Takeda S, Hata T, Takeuchi Y, Kawada Y, Harita T, Seki J, Akamatsu S, Hasegawa S, Bruining N, Brugaletta S, de Winter S, Muramatsu T, Onuma Y, Serruys P, Ikeguchi S,. Long-term (>10 years) clinical outcomes of first-in-man biodegradable poly- l -lactic acid coronary stents: Igaki-Tamai stents. Circulation 2012; 125: 2343-2353.
13. Ormiston JA, Serruys PW,. Bioabsorbable coronary stents. Circ Cardiovasc Interv 2009; 2: 255-260.
14. Ormiston J, Serruys PW, Regar E, Dudek D, Thuesen L, Webster M, Onuma Y, Garcia-Garcia H, McGreevy R, Veldhof S,. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): A prospective open-label trial. Lancet 2008; 371: 899-907.
15. Schulze R,. REVA Medical, Inc. Bioresorbable stent. Presented at: Cardiovascular Revascularization Therapies Conference; March 7-9, 2007; Washington, DC.
16. Walksman R,. Update on bioabsorbable stent: From bench to clinical. J Interv Cardiol 2006: 19: 414-421.
17. Peuster M, Wohlsein P, Brugmann M, Seidler K, Fink C, Brauer H, Fischer A, Hausdorf G,. A novel approach to temporary stenting: Degradable cardiovascular stents produced from corrodible metal-results 6-18 months after implantation into New Zealand white rabbits. Heart 2001; 86: 563-569.
18. Heublein B, Rohde R, Kaese V, Niemeyer M, Hartung W, Haverich A,. Biocorrosion of magnesium alloys: A new principle in cardiovascular implant technology? Heart 2003; 89: 651-656.
19. Di Mario C, Griffiths H, Goktekin O, Peeters N, Verbrist J, Bosiers M, Deloose K, Heublein B, Rohde R, Kasese V, Ilsley C, Erbel R,. Drug-eluting bioabsorbable magnesium stent. J Interv Cardiol 2004; 17: 391-395.
20. Zartner P, Cesnjevar R, Singer H, Weyand M,. First successful implantation of a biodegradable metal stent into the left pulmonary artery of a preterm baby. Cathet Cardiovasc Interven 2005; 66: 590-594.
21. Schranz D, Zartner P, Michel-Behnke I, Akintürk H,. Bioabsorbable metal stents for percutaneous treatment of critical recoarctation of the aorta in a newborn. Cathet Cardiovasc Interven 2006; 67: 671-673.
22. Barragan P, Rieu R, Garitey V, Roquebert PO, Sainsous J, Silvestri M, Bayet G,. Elastic recoil of coronary stents: A comparative analysis. Catheter Cardiovasc Interv 2000; 50: 112-119.
23. Egan MJ, Trask AJ, Baker PB, Lawrence J, Ladich E, Virmani R, Hill SL, Cheatham JP, Galantowicz M, Lucchesi PA, Kovalchin JP,. Histopathologic evaluation of patent ductus arteriosus stents after hybrid stage I palliation. Pediatr Cardiol 2011; 32: 413-417.
24. Engelberg I, Kohn J,. Physico-mechanical properties of degradable polymers used in medical applications: A comparative study. Biomaterials 1991; 12: 292-304.
25. Rosa DS, Guedes CGF, Bardi MAG,. Evaluation of thermal, mechanical and morphological properties of PCL/CA and PCL/CA/PE-g-GMA blends. Polym Test 2007; 26: 209-215.
26. Unverdorben M, Spielberger A, Schywalsky M, Labahn D, Hartwig S, Schneider M, Lootz D, Behrend D, Schmitz K, Degenhardt R, Schaldach M, Vallbracht C,. A polyhyroxybutyrate biodegradable stent: Preliminary experience in the rabbit. Cardiovasc Intervent Radiol 2002; 25: 127-132.